The effect of vitamin D on patients with Sepsis
Phase 2
- Conditions
- Sepsis.Sepsis, unspecified
- Registration Number
- IRCT2016090823552N8
- Lead Sponsor
- Arak University of Medical Sciences, Vice Chancellor for Research
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 160
Inclusion Criteria
Age greater than 18 years old; Sepsis diagnosis and infection source; Patients satisfaction
Exclusion criteria: Calcium level greater than or equal to 10 mg/dl; Vitamin D intake during 7 days ago; History of parathyroid diseases; Metabolic bone disease; Sarcoidosis; End stage renal disease (ESRD); Impending death; Pregnancy.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Serum Ca level. Timepoint: 3 months after injection. Method of measurement: mg/dl.;Serum Vitamin D level. Timepoint: 3 months after injection. Method of measurement: mg/dl.;Tumor necrosis factor alpha. Timepoint: 3 months after injection. Method of measurement: ELISA.;Interleukin 10. Timepoint: 3 months after injection. Method of measurement: ELISA.
- Secondary Outcome Measures
Name Time Method